Get the Daily Brief
Latest Biotech News
Nanotein and Sartorius Stedim Partner to Advance Cell Therapy Manufacturing
Sartorius Stedim Biotech has partnered with Nanotein Technologies, acquiring a minority stake to support commercialization and joint development of immune cell activation solutions based on...
Gut Microbiome Identified as Cause of Fibromyalgia-Like Pain in Mice
Researchers have demonstrated that fecal microbiome transplantation from fibromyalgia patients induces chronic pain symptoms in germ-free mice, establishing a causal role of gut microbes in...
Machine Learning Enhances Cardiovascular Diagnosis and Prognosis
Advances in machine learning have led to novel computational models that significantly improve prediction, diagnosis, and management of heart diseases such as stroke and myocardial infarction....
Neuroprosthetics Innovate Gut Motility and Metabolic Regulation
A novel gastrointestinal neuroprosthetic device has been developed to interface with the enteric nervous system, enabling precise neuromodulation of gut motility and metabolism. This bioelectronic...
Vinay Prasad Reinstated at FDA’s CBER After Abrupt Departure
Vinay Prasad has been reinstated as the director of the Center for Biologics Evaluation and Research (CBER) at the FDA, just weeks after his unexpected departure amid political controversy. The...
FDA Welcomes Back Vinay Prasad Amid Biotech Turmoil
Vinay Prasad has been reinstated as the director of the FDA's Center for Biologics Evaluation and Research (CBER) just weeks after his abrupt ouster, following internal controversy and political...
Novartis’ Ianalumab Wins Phase 3 Sjögren’s Trials
Novartis announced positive results from two pivotal Phase 3 clinical trials (Neptunus 1 and 2) demonstrating that its antibody drug ianalumab significantly reduced disease activity in patients...
Quanterix Downgraded Amid Integration and Market Weakness
Canaccord Genuity downgraded Quanterix’s stock from Buy to Hold, cutting its price target from $12 to $5 after the company's Q2 2025 revenues fell 29% year-over-year due to weak pharmaceutical and...
Exact Sciences and Freenome Team on Colorectal Cancer Screening
Exact Sciences is acquiring U.S. rights to Freenome’s colorectal cancer liquid biopsy test with a $75 million upfront payment, positioning to challenge Guardant Health in the expanding early...
AI Advances Enhance Emergency Care and Medical Imaging
Research teams have unveiled AI-driven models that significantly improve hospital admission predictions from emergency departments, aiming to reduce overcrowding and enhance patient care...
Microbial Links to Neurological Disorders Revealed
Recent studies have elucidated how gut and microbial flora influence neurodegenerative and chronic pain conditions. Research implicates specific Desulfovibrio bacterial strains in...
Boston Life Sciences Real Estate Market Faces Record Vacancies
Greater Boston’s life sciences real estate sector confronts unprecedented vacancy rates, reaching 29.7% including subleases, fueled by speculative construction exceeding tenant demand amid a...
Emerging Therapies and Biotechnology Innovations
Several breakthrough biological and synthetic technologies are advancing therapeutic frontiers. This includes a multivalent mRNA vaccine offering protection against monkeypox in animal models;...
Regulatory and Market Challenges in Pharma Access and Pricing
Rising formulary restrictions and patient out-of-pocket costs exacerbate prescription abandonment, despite large pharma investments in copay assistance that remain under-recognized by patients....
Novartis Claims Twin Phase 3 Wins in Sjögren's Syndrome Trials
Novartis announced successful outcomes from two phase 3 trials of ianalumab, a B-cell-depleting antibody targeting BAFF-R, in treating systemic autoimmune Sjögren's syndrome. The Neptunus 1 and 2...
Vinay Prasad Returns to FDA Amid Controversy
Vinay Prasad has unexpectedly rejoined the FDA to lead the Center for Biologics Evaluation and Research (CBER), weeks after stepping down amid tensions surrounding gene therapy regulation and...
Microbiome’s Role in Fibromyalgia Pain Mechanisms
New research using germ-free mouse models demonstrates a causal relationship between altered gut microbiota and fibromyalgia-like chronic pain. Fecal microbiome transplants from fibromyalgia...
Sarepta Addresses Patient Deaths in Elevidys Gene Therapy Reports
Sarepta Therapeutics clarified that two patient deaths associated with their Duchenne muscular dystrophy gene therapy Elevidys, reported in FDA adverse event databases, were unrelated to...
Regulatory Hurdles Reshape Pharma Marketing and Patient Access
The pharmaceutical industry faces growing challenges in converting direct-to-consumer awareness campaigns into actual medication adherence due to escalating payer restrictions and high...
New AI Model Advances Stroke Imaging Precision
A novel deep learning model named DeepISLES, validated clinically, promises to significantly improve ischemic stroke lesion segmentation. By reliably delineating stroke-affected regions, this AI...